1. Cystic fibrosis in the United Kingdom, 1968–88: incidence, population and survival;Dodge, J.A.; Morrison, S.; Lewis, P.A.; Coles, E.C.; Geddes, D.; Russell, G.;Paediatr Perinatol Epidemiol,1993
2. Cystic Fibrosis Foundation. Patient registry: 1991 Annual Data Report,1992
3. Cystic fibrosis: current survival and population estimates to the year;Elborn, J.S.; Shale, D.J.; Britton, JR;Thorax,2000
4. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone;Regelmann, W.E.; Elliott, G.R.; Warwick, W.J.; Clawson, C.C.;Am Rev Respir Dis,1990
5. Development of Pseudomonas aeruginosa strains resistant to carbenicillin, azlocillin, piperacillin and tobramycin during chemotherapy in cystic fibrosis patients;Hoiby, N.; Heilesen, A.; Moller, N.E.;Monogr Paediatr,1981